U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187861187861HuMax-CD20 in Chronic Lymphocytic LeukemiaWithdrawnNo Results AvailableChronic Lymphocytic LeukemiaDrug: HuMax-CD20https://ClinicalTrials.gov/show/NCT00093314
187862187862Levosimendan Versus Dobutamine in Shock PatientsRecruitingNo Results AvailableCardiogenic Shock|Septic ShockDrug: Levosimendan|Drug: Dobutaminehttps://ClinicalTrials.gov/show/NCT00093301
187863187863Major Depressive Disorder In The ElderlyCompletedNo Results AvailableDepressive Disorder, MajorDrug: bupropion XLhttps://ClinicalTrials.gov/show/NCT00093288
187864187864HP184 in Chronic Spinal Cord Injury SubjectsCompletedNo Results AvailableSpinal Cord InjuryDrug: HP184https://ClinicalTrials.gov/show/NCT00093275
187865187865Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)CompletedNo Results AvailableHypertensionDrug: clevidipine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00093262
187866187866Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)CompletedNo Results AvailableHypertensionDrug: clevidipine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00093249
187867187867Impact of Gum Infection on Heart DiseaseActive, not recruitingNo Results AvailableCardiovascular Disease|Periodontal DiseaseProcedure: Periodontal therapyhttps://ClinicalTrials.gov/show/NCT00093236
187868187868A Safety Study of ABI-007 for In-Stent RestenosisCompletedNo Results AvailableAngina Pectoris|Coronary Artery DiseaseDrug: Paclitaxel Nanoparticle Albumin Bound|Drug: Paclitaxel Nanoparticle Albumin Bound|Drug: Paclitaxel Nanoparticle Albumin Boundhttps://ClinicalTrials.gov/show/NCT00093223
187869187869Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia BCompletedNo Results AvailableHemophilia BDrug: rFIX|Drug: rFIX-Rhttps://ClinicalTrials.gov/show/NCT00093210
187870187870Safety of KAI-9803 for Injection With Angioplasty Following Heart AttackCompletedNo Results AvailableMyocardial InfarctionDrug: KAI-9803 for Injection|Drug: KAI-9803 for Injection|Drug: KAI-9803 for Injection|Drug: KAI-9803 for Injection|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00093197
187871187871Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCICompletedNo Results AvailableMyocardial InfarctionDrug: Angiomax (bivalirudin) anticoagulanthttps://ClinicalTrials.gov/show/NCT00093184
187872187872Study Evaluating rFIX; BeneFIX® in Hemophilia BCompletedNo Results AvailableHemophilia BDrug: rFIXhttps://ClinicalTrials.gov/show/NCT00093171
187873187873Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)CompletedNo Results AvailableUnstable Angina|Myocardial Infarction|Acute DiseaseDrug: Angiomax (bivalirudin) anticoagulanthttps://ClinicalTrials.gov/show/NCT00093158
187874187874Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast CancerCompletedHas ResultsBreast CancerDrug: Albumin-bound paclitaxel|Drug: Carboplatin|Drug: Herceptin®https://ClinicalTrials.gov/show/NCT00093145
187875187875Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous RadiotherapyTerminatedNo Results AvailableCarcinoma, Non-small Cell Lung|Lung CancerDrug: Satraplatinhttps://ClinicalTrials.gov/show/NCT00093132
187876187876Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma|MetastasesDrug: ABI-007https://ClinicalTrials.gov/show/NCT00093119
187877187877Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNo Results AvailableChronic Hepatitis CDrug: Viramidine|Drug: Ribavirin|Drug: pegylated interferon alfa-2ahttps://ClinicalTrials.gov/show/NCT00093093
187878187878Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)CompletedNo Results AvailableLeiomyosarcoma|Liposarcoma|Osteosarcoma|Sarcoma, Soft Tissue|MetastasesDrug: ridaforolimushttps://ClinicalTrials.gov/show/NCT00093080
187879187879Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusCompletedNo Results AvailableBacterial Endocarditis|BacteremiaDrug: daptomycinhttps://ClinicalTrials.gov/show/NCT00093067
187880187880Cranberry Juice for Treatment of Urinary Tract InfectionsCompletedNo Results AvailableUrinary Tract InfectionsDrug: Cranberry juice|Dietary Supplement: Placebo cranberry juicehttps://ClinicalTrials.gov/show/NCT00093054
187881187881Zalutumumab in Head and Neck CancerCompletedHas ResultsHead and Neck NeoplasmsDrug: Zalutumumabhttps://ClinicalTrials.gov/show/NCT00093041
187882187882Study of Bortezomib and Revlimidâ„¢ for Patients Relapsing or Progressing on Total Therapy IICompletedNo Results AvailableMultiple MyelomaDrug: CC-5013 (Revlimidâ„¢)|Drug: bortezomibhttps://ClinicalTrials.gov/show/NCT00093028
187883187883Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)CompletedHas ResultsKidney Disease|Diabetes Mellitus|AnemiaDrug: Placebo|Drug: darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00093015
187884187884Fulvestrant (FASLODEXâ„¢) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCompletedNo Results AvailableBreast CancerDrug: Fulvestranthttps://ClinicalTrials.gov/show/NCT00093002
187885187885Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)CompletedNo Results AvailableAsthmaDrug: montelukast sodium|Drug: placebohttps://ClinicalTrials.gov/show/NCT00092989
187886187886Study Evaluating ReFacto® in Hemophilia A Undergoing Major SurgeryCompletedNo Results AvailableHemophilia ADrug: ReFactohttps://ClinicalTrials.gov/show/NCT00092976
187887187887Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)CompletedNo Results AvailableMigraineDrug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day|Drug: Comparator: placebo / Duration of Treatment: 1 dayhttps://ClinicalTrials.gov/show/NCT00092963
187888187888Exercise in Women at Risk for Breast CancerCompletedNo Results AvailableBreast NeoplasmsBehavioral: Physical activityhttps://ClinicalTrials.gov/show/NCT00092950
187889187889Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantCompletedNo Results AvailableGranulomatous Disease|ChronicDrug: Busulfanhttps://ClinicalTrials.gov/show/NCT00092937
187890187890Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: TRAIL-R1 mAb (TRM-1;HGS-ETR1)https://ClinicalTrials.gov/show/NCT00092924

* Görseller ve İçerik tekif hakkına sahip olabilir